Medicaid Extenders Act of 2019

Medicaid access and coverage, Sunshine, medically complex children, access and affordability, transparency, Medicaid Value Based Payment rule H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act H.R. 133 - Consolidated Appropriations Act, 2021

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medicaid Drug Rebate Program, coverage, state program operations, waivers, gene therapy, value based contracting, Medicaid Value Based Payment rule H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act H.R. 133 - Consolidated Appropriations Act, 2021

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

drug coverage and reimbursement, Medicaid, Medicare, Part B, Part D 6 protected classes, vial size, authorized generics, AMP CAP value based contracting, access and affordability H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act S. 3013 - Encouraging Innovative Benefit Design to Lower Costs for Seniors Act S. 3129 - Lower Costs, More Cures Act of 2019 H.R. 133 - Consolidated Appropriations Act, 2021

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Medicare priorities, coverage and payment policies, discount cards, MedPAC H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 133 - Consolidated Appropriations Act, 2021 no specific bill, Sunshine implementation, Part B, Medicare Part D, Smoking cessation, value based arrangements, drug pricing, benefit redesign

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act S. 3013 - Encouraging Innovative Benefit Design to Lower Costs for Seniors Act S. 3129 - Lower Costs, More Cures Act of 2019 H.R. 133 - Consolidated Appropriations Act, 2021 no specific bills, Medicare and Medicaid Drug Reimbursement, Medicaid Rebate, dual eligibles, Sunshine, discount cards, MedPAC, Alternative Payment Models, Value Based Purchasing, coding, CMMI, Part B, Part D, non-interference, prescription drug access and affordability, transparency, rebates, value based arrangements, benefit redesign, international reference pricing, Medicare drug cards, Medicaid Value Based Payment rule, Medicaid waivers

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 133 - Consolidated Appropriations Act, 2021 no specific bills, access to contraception, immunization access, MedPAC, icd-10, Part D, CMMI, Vaccines for Children Program, Coding, prescription drug access and affordability, value based arrangements, Medicaid, Medicare Part B, Medicare Part D, rebate cap, benefit design, patient out of pocket

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 133 - Consolidated Appropriations Act, 2021 no specific bill, program integrity, recovery audit, third party liability, pre-payment, verification, opioids, payfors, appeals, extenders

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 133 - Consolidated Appropriations Act, 2021 no specific bill, Medicare, Medicaid, Rate Notice and Call Letter, Medigap, Medicaid Program Operations, Medicare Operations, MLR, Money Follows the Person, sequestration

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Six protected classes, Medicare Part D, HIV, Medicaid H.R. 259 - Medicaid Extenders Act of 2019 S. 3129 - Lower Costs, More Cures Act of 2019 Pharmaceutical access & affordability Part D benefit redesign Hepatitis C HIV Coronavirus therapeutics Medicaid Value Based Payment rule H.R. 133 - Consolidated Appropriations Act, 2021

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Legislative and administrative monitoring and outreach on healthcare policy. Legislative and administrative monitoring and outreach on prescription drug pricing/PBMs. Legislative and administrative monitoring and outreach on policy issues affecting Medicaid programs. Legislative and administrative monitoring and outreach on the implementation of the Affordable Care Act (ACA) (P.L. 111-148) Legislative and administrative monitoring and outreach on issues regarding the health insurance tax (HIT). Legislative outreach related to executive action surrounding the HHS Rebate rule. S. 4775, Delivering Immediate Relief to America's Families, Schools and Small Businesses Act. Legislative outreach and monitoring the implementation of H.R. 259, Medicaid Extenders Act of 2019 (P.L. 116-3). H.R. 3 Lower Drug Costs Now Act of 2019 H.R. 987 Strengthening Health Care and Lowering Prescription Drug Costs Act H.R. 1398 Health Insurance Tax Relief Act of 2019 H.R. 2447 Jobs and Premium Protection Act S. 172 Health Insurance Tax Relief Act of 2019 S. 1895 Lower Health Care Costs Act HR 6926 MIND Act H.R. 133, Consolidated Appropriations Act, 2021 (P.L. 116-260).

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES

PL 111-148 - The Patient Protection and Affordable Care Act, implementation H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 1226/S. 317 - ACE Kids Act of 2019 H.R. 133 - Consolidated Appropriations Act, 2021 no specific bills, Medicare and Medicaid Fraud, Advantage, Medicare Part D, Medicaid, Medicaid expansion, Electronic Prescribing, Dual Eligibles, Medigap reform, claims resolution, risk adjustment, Delivery System Reform, Special Needs Plans, Star Ratings, call letter, program integrity, Alzheimer's care, telehealth, chronic care, coding intensity, Medicaid per capita caps, block grant, long term services and supports, value based purchasing, Medicaid MLR, spread pricing, social determinants of health, mental health and substance abuse

Client expense: Not reported · Firm income: $90,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

Legislative and administrative monitoring and outreach on healthcare policy. Legislative and administrative monitoring and outreach on prescription drug pricing/PBMs. Legislative and administrative monitoring and outreach on policy issues affecting Medicaid programs. Legislative and administrative monitoring and outreach on the implementation of the Affordable Care Act (ACA) (P.L. 111-148) Legislative and administrative monitoring and outreach on issues regarding the health insurance tax (HIT). Legislative outreach related to executive action surrounding the HHS Rebate rule. Legislative outreach and monitoring regarding COVID-19 response, including the implementation of: HR 748 CARES Act (PL 116-136); HR 6201 Families First Coronavirus Act (PL 116-127); and HR 1425 Patient Protection and Affordable Care Enhancement Act. HR 6800 The HEROES Act The HEALS Act (S. 4317 - S 4324) S. 4775, Delivering Immediate Relief to America's Families, Schools and Small Businesses Act. Legislative outreach and monitoring the implementation of H.R. 259, Medicaid Extenders Act of 2019 (P.L. 116-3). H.R. 3 Lower Drug Costs Now Act of 2019 H.R. 987 Strengthening Health Care and Lowering Prescription Drug Costs Act H.R. 1398 Health Insurance Tax Relief Act of 2019 H.R. 2447 Jobs and Premium Protection Act S. 172 Health Insurance Tax Relief Act of 2019 S. 1895 Lower Health Care Costs Act HR 6926 MIND Act

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Administration drug pricing proposals. HCV testing, screening and linkage to care programs. Medicaid and Medicare coverage, access and reimbursement issues for Hepatitis C, HIV, and oncology products. Medicare Part D reform and benefit redesign. CMS rules related to Notice of Benefit and Payment Parameters (NBPP), hospital inpatient payments, and value-based purchasing arrangements. H.R.3 - Lower Drug Costs Now Act of 2019 H.R.19 - Lower Costs, More Cures Act of 2019 H.R.259 - Medicaid Extenders Act of 2019 H.R. 7647 - To provide for a COVID-19-related delay regarding annual limitation on cost-sharing for group health plans and individual and small group health insurance coverage S.2543 - The Prescription Drug Pricing Reduction Act of 2019 S.3129 - Lower Costs, More Cures Act of 2019

Client expense: $1,810,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office

H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 no specific bills, access to contraception, immunization access, MedPAC, icd-10, Part D, CMMI, Vaccines for Children Program, Coding, prescription drug access and affordability, value based arrangements, Medicaid, Medicare Part B, Medicare Part D, rebate cap, benefit design, patient out of pocket

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Medicare priorities, coverage and payment policies, discount cards, MedPAC H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 no specific bill, Sunshine implementation, Part B, Medicare Part D, Smoking cessation, value based arrangements, drug pricing, benefit redesign

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 no specific bill, program integrity, recovery audit, third party liability, pre-payment, verification, opioids, payfors, appeals, extenders

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 no specific bill, Medicare, Medicaid, Rate Notice and Call Letter, Medigap, Medicaid Program Operations, Medicare Operations, MLR, Money Follows the Person

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Medicaid Drug Rebate Program, coverage, state program operations, waivers, gene therapy, value based contracting H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act S. 3013 - Encouraging Innovative Benefit Design to Lower Costs for Seniors Act S. 3129 - Lower Costs, More Cures Act of 2019 no specific bills, Medicare and Medicaid Drug Reimbursement, Medicaid Rebate, dual eligibles, Sunshine, discount cards, MedPAC, Alternative Payment Models, Value Based Purchasing, coding, CMMI, Part B, Part D, non-interference, prescription drug access and affordability, transparency, rebates, value based arrangements, benefit redesign, international reference pricing

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medicaid access and coverage, Sunshine, medically complex children, access and affordability, transparency H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

PL 111-148 - The Patient Protection and Affordable Care Act, implementation H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 1226/S. 317 - ACE Kids Act of 2019 no specific bills, Medicare and Medicaid Fraud, Advantage, Medicare Part D, Medicaid, Medicaid expansion, Electronic Prescribing, Dual Eligibles, Medigap reform, claims resolution, risk adjustment, Delivery System Reform, Special Needs Plans, Star Ratings, call letter, program integrity, Alzheimer's care, telehealth, chronic care, coding intensity, Medicaid per capita caps, block grant, long term services and supports, value based purchasing, Medicaid MLR, spread pricing, social determinants of health, mental health and substance abuse

Client expense: Not reported · Firm income: $90,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

Six protected classes, Medicare Part D, HIV, Medicaid H.R. 259 - Medicaid Extenders Act of 2019 S. 3129 - Lower Costs, More Cures Act of 2019 Pharmaceutical access & affordability Part D benefit redesign Hepatitis C HIV Coronavirus therapeutics

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

drug coverage and reimbursement, Medicaid, Medicare, Part B, Part D 6 protected classes, vial size, authorized generics, AMP CAP value based contracting, access and affordability H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act S. 3013 - Encouraging Innovative Benefit Design to Lower Costs for Seniors Act S. 3129 - Lower Costs, More Cures Act of 2019

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Administration drug pricing proposals. HCV testing, screening and linkage to care programs. Medicaid and Medicare coverage, access and reimbursement issues for Hepatitis C, HIV, and oncology products. Medicare Part D reform and benefit redesign. 2021 Notice of Benefit and Payment Parameters (NBPP) proposed rule and CMS rules related to hospital inpatient payments and value-based purchasing arrangements. S.2543 - The Prescription Drug Pricing Reduction Act of 2019 S.3129 - Lower Costs, More Cures Act of 2019 H.R.3 - Lower Drug Costs Now Act of 2019 H.R.19 - Lower Costs, More Cures Act of 2019 H.R.259 - Medicaid Extenders Act of 2019

Client expense: $1,260,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office

H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 no specific bills, access to contraception, immunization access, MedPAC, icd-10, Part D, CMMI, Vaccines for Children Program, Coding, prescription drug access and affordability, value based arrangements, Medicaid, Medicare Part B, Medicare Part D, rebate cap, benefit design, patient out of pocket

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

drug coverage and reimbursement, Medicaid, Medicare, Part B, Part D 6 protected classes, vial size, authorized generics, AMP CAP value based contracting, access and affordability H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act S. 3013 - Encouraging Innovative Benefit Design to Lower Costs for Seniors Act S. 3129 - Lower Costs, More Cures Act of 2019

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Six protected classes, Medicare Part D, HIV, Medicaid H.R. 259 - Medicaid Extenders Act of 2019 S. 3129 - Lower Costs, More Cures Act of 2019 Pharmaceutical access & affordability Part D benefit redesign Hepatitis C HIV Coronavirus therapeutics

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Legislative and administrative monitoring and outreach on healthcare policy. Legislative and administrative monitoring and outreach on prescription drug pricing/PBMs. Legislative and administrative monitoring and outreach on policy issues affecting Medicaid programs. Legislative and administrative monitoring and outreach on the implementation of the Affordable Care Act (ACA) (P.L. 111-148) Legislative and administrative monitoring and outreach on issues regarding the health insurance tax (HIT). H.R. 3 Lower Drug Costs Now Act of 2019 H.R. 259 Medicaid Extenders Act of 2019 (P.L. 116-3). H.R. 987 Strengthening Health Care and Lowering Prescription Drug Costs Act H.R. 1398 Health Insurance Tax Relief Act of 2019 H.R. 2447 Jobs and Premium Protection Act S. 172 Health Insurance Tax Relief Act of 2019 S. 1895 Lower Health Care Costs Act HR 6201 Families First Coronavirus Act (PL 116-127) HR 748 CARES Act (PL 116-136) HR 6926 MIND Act HR 1425 Patient Protection and Affordable Care Enhancement Act HR 6800 The HEROES Act HR 266, Paycheck Protection Program and Health Care Enhancement Act (PL 116-139)

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES

Medicaid access and coverage, Sunshine, medically complex children, access and affordability, transparency H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act S. 3013 - Encouraging Innovative Benefit Design to Lower Costs for Seniors Act S. 3129 - Lower Costs, More Cures Act of 2019 no specific bills, Medicare and Medicaid Drug Reimbursement, Medicaid Rebate, dual eligibles, Sunshine, discount cards, MedPAC, Alternative Payment Models, Value Based Purchasing, coding, CMMI, Part B, Part D, non-interference, prescription drug access and affordability, transparency, rebates, value based arrangements, benefit redesign, international reference pricing

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medicaid Drug Rebate Program, coverage, state program operations, waivers, gene therapy, value based contracting H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Medicare priorities, coverage and payment policies, discount cards, MedPAC H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 no specific bill, Sunshine implementation, Part B, Medicare Part D, Smoking cessation, value based arrangements, drug pricing, benefit redesign

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

H.R. 259 - Medicaid Extenders Act of 2019 no specific bill, Medicare, Medicaid, Rate Notice and Call Letter, Medigap, Medicaid Program Operations, Medicare Operations, MLR, Money Follows the Person H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 no specific bill, program integrity, recovery audit, third party liability, pre-payment, verification, opioids, payfors, appeals, extenders

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

PL 111-148 - The Patient Protection and Affordable Care Act, implementation H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 1226/S. 317 - ACE Kids Act of 2019 no specific bills, Medicare and Medicaid Fraud, Advantage, Medicare Part D, Medicaid, Medicaid expansion, Electronic Prescribing, Dual Eligibles, Medigap reform, claims resolution, risk adjustment, Delivery System Reform, Special Needs Plans, Star Ratings, call letter, program integrity, Alzheimer's care, telehealth, chronic care, coding intensity, Medicaid per capita caps, block grant, long term services and supports, value based purchasing, Medicaid MLR, spread pricing, social determinants of health, mental health and substance abuse

Client expense: Not reported · Firm income: $90,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

Administration drug pricing proposals. HCV testing, screening and linkage to care programs. Medicaid and Medicare coverage, access and reimbursement issues for Hepatitis C, HIV, and oncology products. Medicare Part D reform and benefit redesign. 2021 Notice of Benefit and Payment Parameters (NBPP) proposed rule and CMS rules related to hospital inpatient payments. S.2543 - The Prescription Drug Pricing Reduction Act of 2019 S.3129 - Lower Costs, More Cures Act of 2019 H.R.3 - Lower Drug Costs Now Act of 2019 H.R.19 - Lower Costs, More Cures Act of 2019 H.R.259 - Medicaid Extenders Act of 2019

Client expense: $2,450,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office

1. H.R. 748 - Coronavirus Aid, Relief, and Economic Security Act (CARES Act) - all provisions 2. H.R. 6201 - Families First Coronavirus Response Act - all provisions 3. H.R. 259 - Medicaid Extenders Act of 2019 - Extension of protection for Medicaid recipients of home and community-based services against spousal impoverishment - all provisions 4.. H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 - Extension of protection for Medicaid recipients of home and community-based services against spousal impoverishment - all provisions

Client expense: $75,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Treasury, Dept of

Six protected classes, Medicare Part D, HIV, Medicaid H.R. 259 - Medicaid Extenders Act of 2019 S. 3129 - Lower Costs, More Cures Act of 2019 Pharmaceutical access & affordability Part D benefit redesign Hepatitis C HIV

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medicaid Drug Rebate Program, coverage, state program operations, waivers, gene therapy, value based contracting H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Legislative and administrative monitoring and outreach on healthcare policy. Legislative and administrative monitoring and outreach on prescription drug pricing/PBMs. Legislative and administrative monitoring and outreach on policy issues affecting Medicaid programs. Legislative and administrative monitoring and outreach on the implementation of the Affordable Care Act (ACA) (P.L. 111-148) Monitor the implementation of SAMHSA final rule regarding the Confidentiality of substance use disorder patient records (83 FR 239). Legislative and administrative monitoring and outreach on issues regarding the health insurance tax (HIT). H.R. 3 Lower Drug Costs Now Act of 2019 H.R. 259 Medicaid Extenders Act of 2019 (P.L. 116-3). H.R. 987 Strengthening Health Care and Lowering Prescription Drug Costs Act H.R. 1398 Health Insurance Tax Relief Act of 2019 H.R. 2447 Jobs and Premium Protection Act S. 172 Health Insurance Tax Relief Act of 2019 S. 1895 Lower Health Care Costs Act H.Res.826 Expressing disapproval of the Trump administrations harmful actions towards Medicaid HR 6201 Families First Coronavirus Act (PL 116-127) HR 748 CARES Act (PL 116-136)

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES

Medicaid access and coverage, Sunshine, medically complex children, access and affordability, transparency H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medicaid Drug Rebate Program, coverage, state program operations, waivers, gene therapy, value based contracting H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act S. 3013 - Encouraging Innovative Benefit Design to Lower Costs for Seniors Act S. 3129 - Lower Costs, More Cures Act of 2019 no specific bills, Medicare and Medicaid Drug Reimbursement, Medicaid Rebate, dual eligibles, Sunshine, discount cards, MedPAC, Alternative Payment Models, Value Based Purchasing, coding, CMMI, Part B, Part D, non-interference, prescription drug access and affordability, transparency, rebates, value based arrangements, benefit redesign, international reference pricing

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medicare priorities, coverage and payment policies, discount cards, MedPAC H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 no specific bill, Sunshine implementation, Part B, Medicare Part D, Smoking cessation, value based arrangements, drug pricing, benefit redesign

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

drug coverage and reimbursement, Medicaid, Medicare, Part B, Part D 6 protected classes, vial size, authorized generics, AMP CAP value based contracting, access and affordability H.R. 259 - Medicaid Extenders Act of 2019 H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act S. 3013 - Encouraging Innovative Benefit Design to Lower Costs for Seniors Act S. 3129 - Lower Costs, More Cures Act of 2019

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE